Glaxosmithkline Capital Inc
Pharmaceutical company · Wilmington, Delaware, United States
Glaxosmithkline Capital Inc is a pharmaceutical company headquartered in Wilmington, Delaware, United States.
Profile compiled from public records. Is this your company? Request a correction or update
Glaxosmithkline Capital at a glance
Typepharmaceutical company
HeadquartersWilmington, Delaware, United States
SEC industryPharmaceutical Preparations
SEC CIK1224462
Frequently asked questions about Glaxosmithkline Capital
Where is Glaxosmithkline Capital headquartered?
Glaxosmithkline Capital Inc is headquartered in Wilmington, Delaware, United States.
What does Glaxosmithkline Capital do?
Glaxosmithkline Capital Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- Prelude Therapeutics IncWilmington, Delaware, United States
- Dusa Pharmaceuticals IncWilmington, Massachusetts, United States
- NeuroRx, Inc.Wilmington, Delaware, United States
- NRX Pharmaceuticals, Inc.Wilmington, Delaware, United States
- Applied Molecular Transport Inc.Wilmington, Delaware, United States
- ImmunoRx Pharma, Inc.Wilmington, Delaware, United States
- Gladius Pharmaceuticals CorpWilmington, Delaware, United States
- Sarkana Pharma, Inc.Wilmington, Delaware, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences